Valuation (52%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -0.89 | N/A |
| PEG Ratio (TTM) | 0.02 | N/A |
| P/S Ratio (TTM) | 3.49 | N/A |
| P/B Ratio (TTM) | 0.41 | N/A |
| P/FCF Ratio (TTM) | 68.91 | N/A |
| Price to 5YR AVG Earnings Ratio | 5.51 | N/A |
| Price to 5YR AVG FCF Ratio | -1.48 | N/A |
Profitability (10%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -16.55% | N/A |
| ROE (TTM) | -38.86% | N/A |
| Net Profit Margin (TTM) | -393.26% | N/A |
| ROIC 5YR AVG | 4.15% | N/A |
Growth (37%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -196.77% | -12.86% | -33.09% |
| Revenue | 41.19% | 26.26% | 7.03% |
| Net Income | -193.18% | 1.35% | -24.00% |
| Cash Flow | -11.05% | 22.15% | 5.19% |
Health (32%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 2.75 | N/A |
| Quick Ratio (TTM) | 2.75 | N/A |
| D/E Ratio (TTM) | 1.72 | N/A |
| Interest Coverage (TTM) | -1.31 | N/A |
| Piotroski F-Score | 4 | N/A |
| Altman Z-Score | N/A | N/A |
| LTL to 5YR AVG FCF | -6.40 | N/A |
| Shares Outstanding Growth 5YR AVG | 10.74% | N/A |